An Overview of Heart Attack

In This Article

Table of Contents

A heart attack, or myocardial infarction (MI), occurs when an acute blockage of blood flow causes a portion of the heart to die from lack of oxygen, bringing on symptoms such as chest pain, shortness of breath, and inexplicable anxiety—or none at all. A heart attack is an emergency that requires immediate medical attention followed by treatment ranging from surgery to medication to changes in lifestyle.

In the best-case scenario, a heart attack is a wake-up call—an indication of coronary artery disease (CAD), meaning the heart has been severely damaged. In other instances, a heart attack can produce significant disability and premature death.

Symptoms

A heart attack usually produces significant acute symptoms, including:

  • Chest pain that may radiate to the jaw or arm
  • Dyspnea (shortness of breath)
  • Sweating
  • Sudden nausea or vomiting

However, many people don’t experience these. They may not have chest pain—or any pain—at all. They may describe their symptoms as pressure or nondescript discomfort—“a funny feeling.”

In fact, heart attack symptoms may not even be located in the chest but instead show up the back, shoulders, neck, arms, or the pit of the stomach. Some people even dismiss what they're feeling as heartburn.

Sometimes symptoms of a heart attack are so minor that those who experience them brush them off, figuring they'll go away—and often, they do. When they finally see a doctor, these are the people who likely will be diagnosed as having what's called a silent heart attack.

Complications

Beside immediate symptoms, a heart attack can have dire consequences, some right away, others in the future.

Immediate

If the amount of heart muscle affected by a blocked coronary artery is extensive, a person having a heart attack may experience acute heart failure in which he or she experiences shortness of breath, low blood pressure, lightheadedness or syncope, and multi-organ failure. Unless blood flow is restored to the heart rapidly, these physiological repercussions can be fatal.

In addition, during an acute heart attack, the dying muscle can stop beating normally and begin quivering—a heart rhythm disturbance known as ventricular fibrillation (v-fib). Ventricular fibrillation usually can be treated effectively if it occurs when a person is under medical care; if not treated, v-fib increases the risk of death within the first few hours of a heart attack.

Long-Term

There are three significant long-term consequences of a heart attack:

  • Damage to the heart during a myocardial infarction may leave the organ so weakened that heart failure eventually develops.
  • Depending on the amount of permanent damage done to the heart, the risk of sudden death may be permanently elevated.
  • The very fact that a heart attack has occurred places a person at a very high risk of subsequent heart attacks.

Causes

Most heart attacks occur when an atherosclerotic plaque in a coronary artery suddenly ruptures. The plaque rupture triggers the clotting mechanism within the artery, causing a blood clot to form and block blood flow. If the blockage is severe enough, the heart muscle supplied by that artery begins to die and a heart attack occurs.

Researchers aren't certain why plaques rupture. While sometimes they appear to be triggered by, for example, intense physical or emotional stress, more often they occur sporadically, for no apparent reason, and with no identifiable triggers.

What's more, it isn't clear that the larger plaques doctors tend to worry about (the kind identified after a heart catheterization as being “significant blockages”) are more prone to rupture than smaller ones.

Anyone who has CAD must be regarded as being at risk for a heart attack—whether or not their plaques are labeled as “significant”—and should be treated accordingly.

Types of Heart Attack

A plaque rupture can produce several clinical conditions, which together are categorized as acute coronary syndrome (ACS).

In one of these, unstable angina, the blood clot resulting from a plaque rupture is not large enough (or does not last long enough) to produce permanent damage. Although not regarded as a heart attack, per se, unstable angina without aggressive treatment is often followed by an MI in the near future.

The other ACS conditions are:

  • ST-elevation myocardial infarction (STEMI): The blood clot is so extensive and severe a large part of the heart muscle will die without rapid treatment. STEMI is the most severe type of ACS and is so named because it shows up as a spike in the ST segment of an electrocardiogram (ECG) tracing.
  • Non-ST segment elevation myocardial infarction (NSTEMI): In terms of potential severity, NSTEMI ranks between unstable angina and STEMI in that the blockage of the coronary artery is only partial, but still large enough to cause damage to the heart muscle.

Diagnosis

Diagnosing a heart attack usually isn't difficult when a person is having typical symptoms and says so. Often, however, someone in this situation may they think they're having symptoms related to their heart but will downplay them out of fear—even in a hospital emergency department.

This is understandable but dangerous: The more quickly medical personnel are alerted to the possibility of myocardial infarction, the more quickly they can make (or rule out) that diagnosis.

Besides evaluating obvious symptoms, two tests typically are done to diagnose a heart attack:

  • An electrocardiogram (ECG), a non-invasive test that analyzes the patterns of how the heart beats to reveal abnormal rhythms
  • A blood test to measure cardiac enzymes to detect whether damage to heart cells is occurring)

Every Minute Counts

If you're even the least concerned you're having symptoms originating from your heart, do not hesitate to say that you think you're having a heart attack.

Treatment

A heart attack is a medical emergency. Muscle tissue is actively dying, so immediate treatment is critical. Minutes can make the difference between complete recovery and permanent disability or death. After that, long-term treatment will be necessary.

Once a person is under medical care and an ongoing myocardial infarction has been diagnosed, doctors typically begin two approaches to treatment simultaneously: stabilization and revascularization.

In the majority of cases—especially if treatment is begun quickly—people with acute heart attacks are quite stable within 24 hours. If a person's heart doesn't start again or ​CPR isn't given within four minutes of cardiac arrest, brain damage is, unfortunately, almost guaranteed.

Stabilization

The focus is to treat acute symptoms, relieving stress on the heart muscle, normalizing blood pressure, dealing with the ruptured plaque, and stopping blood clots from forming in the damaged artery. This is done with medication, typically a combination of nitroglycerin, oxygen, morphine, beta-blockers, a statin, aspirin, and another anti-platelet drug such as Plavix (clopidogrel bisulfate).

Revascularization

The goal is to restore blood flow to the dying heart muscle through the blocked coronary artery as quickly as possible. Most permanent cardiac damage can be avoided if the artery can be re-opened within roughly four hours; at least some permanent damage can be prevented if the artery is opened within eight to 12 hours.

In the case of a STEMI, in which the coronary artery is fully blocked, revascularization is done with invasive therapy that typically involves two procedures.

The first is angioplasty, in which a small balloon is inflated in the artery to flatten the plaque that's blocking it. This is followed immediately by the insertion of a stent, a metal device that is positioned inside the artery to keep it propped open so that blood can once again flow through easily.

If this approach is unfeasible or too risky, thrombolytic therapy—administration of a “clot-busting” drug—is used to dissolve the clot and restore blood flow.

Often, an NSTEMI (a partial blockage) can be treated with stabilization measures alone (as can unstable angina). However, most cardiologists believe stenting is more effective for preserving cardiac muscle, and the approach is often the preferred one for both STEMI and NSTEMI. Thrombolytic therapy has been shown to cause more harm than good.

Prevention

After surviving a heart attack, your doctor will focus on treatment aimed at preventing three potential long-term consequences:

Heart Failure

Muscle damaged in a heart attack is converted into scar tissue. This tissue will hold the heart together but will not help the heart do its job. The chance of heart failure after a heart attack depends in large part on the extent of the damage.

It also depends on how the remaining heart muscle adjusts. Often it will respond by changing its shape, a process called cardiac remodeling. A certain amount of remodeling may be beneficial at first, but chronic remodeling can lead to heart failure.

There are two classes of medications used to prevent this:

  • Beta-blockers: These drugs work by blocking the effect of adrenaline on the heart. Two beta-blocker medications often prescribed after a heart attack are Tenormin (atenolol) and Lopressor (metoprolol).
  • Angiotensin-converting enzyme (ACE) inhibitors: These affect an enzyme that contributes to the regulation of blood pressure and the amount of sodium in blood. Examples of ACE inhibitors include Capoten (captopril), Vasotec (enalapril), Zestril (lisinopril), Altace (ramipril), and Mavik (trandolarpril).

Sudden Death

The post-heart attack discussion that is often skipped by cardiologists is the one about sudden death. While hard to talk about, sudden death is a substantial risk for many people after a heart attack, especially those whose hearts have sustained a lot of damage.

Furthermore, the risk of sudden death can be substantially lowered in people whose risk is very high with an implantable defibrillator. Clear guidelines exist regarding which people ought to be considered for an implantable defibrillator after a heart attack.

If your doctor doesn't bring up the topic of sudden death or the idea of a defibrillator, ask him or her about both.

Future Heart Attacks

A person who's survived a heart attack has CAD, and so is at an increased risk for another episode of MI. That risk can be substantially improved with medications and by adopting a healthy lifestyle.

In addition to beta-blockers and ACE inhibitors, most people who have had a heart attack need to be on statins (cholesterol-lowering drugs), an anticoagulant (blood-clot) medication such as aspirin, and possibly medication to treat or prevent further angina (such as nitrates or calcium channel blockers).

Lifestyle measures that substantially lower future cardiac risk include:

It's a lot to be aware of and think about, and this is really just the tip of the iceberg. You may want to develop a post-heart attack checklist with the guidance of your doctor to help you both stay on top of the measures you should be taking to stay healthy after your heart attack.

A Word From Verywell

A heart attack is a serious medical event. Fortunately, with what experts have learned about heart attacks in the last few decades, and with the newer therapies that have been devised to treat these events, the chances of dying or having permanent disability after a heart attack have been greatly diminished. That, however, hinges on knowing the signs and getting help when you need it.

Was this page helpful?

Article Sources

  1. Lu L, Liu M, Sun R, Zheng Y, Zhang P. Myocardial Infarction: Symptoms and Treatments. Cell Biochem Biophys. 2015;72(3):865-7.

    doi:10.1007/s12013-015-0553-4

  2. Lesneski L. Factors influencing treatment delay for patients with acute myocardial infarction. Appl Nurs Res. 2010;23(4):185-90.

    doi:10.1016/j.apnr.2008.09.004

  3. Bhar-amato J, Davies W, Agarwal S. Ventricular Arrhythmia after Acute Myocardial Infarction: 'The Perfect Storm'. Arrhythm Electrophysiol Rev. 2017;6(3):134-139.

    doi:10.15420/aer.2017.24.1

  4. Wilson PWF, Dougla PS, Alpert JS, et al. Prognosis after myocardial infarction. UpToDate.

  5. CL Odendaal (2010) Cardiopulmonary-cerebral resuscitation. Southern African Journal of Anaesthesia and Analgesia, 16:2, 45-60, 

    doi:10.1080/22201173.2010.10872665

  6. Uhlig K, Balk EM, Earley A, Persson R, Garlitski AC, Chen M, et al. Assessment on Implantable Defibrillators and the Evidence for Primary Prevention of Sudden Cardiac Death. AHRQ Health Technology Assessments. 2013.

Additional Reading